Company PharmaTher Holdings Ltd.

PHRM

CA71716H1082

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:56:42 2024-04-25 pm EDT			5-day change	1st Jan Change
0.245 ^CAD	0.00%		+6.52%	-22.22%

Apr. 23	PharmaTher Holdings Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	CI
Apr. 16	PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine	MT

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.

Managers	Title	Age	Since
Fabio Chianelli CEO	Chief Executive Officer	-	19-12-31
Carmelo Marrelli DFI	Director of Finance/CFO	52	20-05-31
Owen van Cauwenberghe PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Beverly Incledon BRD	Director/Board Member	-	20-05-31
Fabio Chianelli CEO	Chief Executive Officer	-	19-12-31
Carlo Sansalone BRD	Director/Board Member	-	20-05-31
Christian Scovenna BRD	Director/Board Member	50	20-05-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	88,169,065	71,690,565 ( 81.31 %)	0	81.31 %

Name	Equities	%	Valuation
Fabio Chianelli 17.58 %	15,498,500	17.58 %	4 M $
Carlo Sansalone 1.134 %	1,000,000	1.134 %	290 000 $
1st Capital Management Group GmbH 0.0567 %	50,000	0.0567 %	14 500 $

PharmaTher Holdings Ltd.

82 Richmond Street East

M5C 1P1, Toronto

http://www.pharmather.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
PHARMATHER HOLDINGS LTD.	-22.22%	15.83M
NOVO NORDISK A/S	+24.17%	556B
JOHNSON & JOHNSON	-6.33%	354B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+7.95%	296B
ASTRAZENECA PLC	+13.45%	233B
NOVARTIS AG	+6.04%	201B
ROCHE HOLDING AG	-10.51%	193B
PFIZER, INC.	-12.26%	143B
AMGEN INC.	-6.47%	144B

Other Pharmaceuticals